Elekta’s Monaco 5.11 treatment planning system takes center stage at 2016 American Association of Physicists in Medicine Annual Meeting
Elekta will showcase the latest version of its treatment planning software, Monaco® version 5.11 at the 58th American Association of Physicists in Medicine (AAPM) Meeting taking place from July 31 - August 4 in Washington DC. Monaco 5.11, which enables users to attain calculation speeds up to four times faster than previous versions, is cloud capable and is currently installed at several customer sites. Monaco continues to utilize multicriteria optimization and Monte Carlo dose calculations for high-quality dependable treatment planning results.
Monaco templates further increase efficiency by allowing users to easily import and export treatment plans, facilitating best practice sharing across departments and organizations. The ability to create multiple prescription plans simultaneously reduces overall planning time as well. Improved data sharing creates opportunities to optimize individual treatment plans.
“Elekta’s Versa HD linear accelerator and Monaco treatment planning system combine unrivalled dose delivery and intelligent dose planning,” says Elekta’s David Mellenberg, PhD, DABR. “The efficiency and precision of Versa HD are enhanced when combined with the Multicriteria Optimization and Gold Standard Monte Carlo calculations in Monaco 5.11. Together, they make dynamic and stereotactic techniques not only possible, but routine practice.”
“We successfully installed Monaco 5.11 at our large center, which treats more than 250 patients daily across two campuses,” says Miller MacPherson, PhD, FCCPM, Head of Physics at The Ottawa Hospital. “VMAT planning is fast and our physics team was able to generate really solid beam models. As a result, we are seeing improvements in IMRT and VMAT QA. We are very pleased with the support we received from Elekta and proud of our physics and planning teams’ accomplishments and hard work transitioning from XiO® to Monaco.”
In addition to Monaco 5.11, the following solutions also will be highlighted at the Elekta booth (#2017):
- The latest version of MOSAIQ®, which provides numerous workflow enhancements including IQ Scripts Plan of the Day, ePrescribing for controlled substances and many other time saving features
- Leksell Gamma Knife® Icon™, the most accurate brain radiosurgery system offering novel technology including true stereotactic CBCT and online adaptive planning capability
- iView Dose software, Elekta’s EPID-based in vivo dosimetry solution, which offers an essential safety check during radiation therapy
- AQUA, a quality management system which offers a full suite of workflow-oriented machine QA tasks
- MOSAIQ Oncology Analytics, which aggregates data to bring clinical, operational and financial insights to the surface
During AAPM, Elekta will host a series of educational events at the Marriott Marquis Washington DC. A User Meeting focusing on commissioning and planning for stereotactic radiation therapy will take place Saturday, July 30 from 10 a.m. to 5 p.m. and a luncheon symposium focusing on emerging techniques including MR-guided radiation therapy will take place Monday, August 1 from noon to 1 p.m.
For more information or to register, visit www.elekta.com/AAPM.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, Email: firstname.lastname@example.org
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, Email: email@example.com
Time zone: EST: Eastern Standard Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com Twitter: @Elekta.